Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2068364191', 'doi': 'https://doi.org/10.1016/0922-4106(93)90095-q', 'title': 'Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes', 'display_name': 'Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes', 'publication_year': 1993, 'publication_date': '1993-07-01', 'ids': {'openalex': 'https://openalex.org/W2068364191', 'doi': 'https://doi.org/10.1016/0922-4106(93)90095-q', 'mag': '2068364191', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/8104153'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/0922-4106(93)90095-q', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210192051', 'display_name': 'European Journal of Pharmacology Molecular Pharmacology', 'issn_l': '0922-4106', 'issn': ['0922-4106', '1872-8251'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5069522699', 'display_name': 'Beth Levant', 'orcid': 'https://orcid.org/0000-0002-8143-9220'}, 'institutions': [{'id': 'https://openalex.org/I210824098', 'display_name': 'Wilmington University', 'ror': 'https://ror.org/00jrtvk29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I210824098']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Beth Levant', 'raw_affiliation_strings': ['Central Nervous System Diseases Research The DuPont Merck Pharmaceutical Company, Wilmington, DE 19880-0400.'], 'affiliations': [{'raw_affiliation_string': 'Central Nervous System Diseases Research The DuPont Merck Pharmaceutical Company, Wilmington, DE 19880-0400.', 'institution_ids': ['https://openalex.org/I210824098']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052614648', 'display_name': 'Dimitri E. Grigoriadis', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I210824098', 'display_name': 'Wilmington University', 'ror': 'https://ror.org/00jrtvk29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I210824098']}, {'id': 'https://openalex.org/I1316910977', 'display_name': 'DuPont (United States)', 'ror': 'https://ror.org/03g3m1w62', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1316910977']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dimitri E. Grigoriadis', 'raw_affiliation_strings': ['Central Nervous System Diseases Research The DuPont Merck Pharmaceutical Company, Wilmington, DE, USA'], 'affiliations': [{'raw_affiliation_string': 'Central Nervous System Diseases Research The DuPont Merck Pharmaceutical Company, Wilmington, DE, USA', 'institution_ids': ['https://openalex.org/I210824098', 'https://openalex.org/I1316910977']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5060147767', 'display_name': 'Errol B. DeSouza', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I210824098', 'display_name': 'Wilmington University', 'ror': 'https://ror.org/00jrtvk29', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I210824098']}, {'id': 'https://openalex.org/I1316910977', 'display_name': 'DuPont (United States)', 'ror': 'https://ror.org/03g3m1w62', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1316910977']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Errol B. DeSouza', 'raw_affiliation_strings': ['Central Nervous System Diseases Research The DuPont Merck Pharmaceutical Company, Wilmington, DE, USA'], 'affiliations': [{'raw_affiliation_string': 'Central Nervous System Diseases Research The DuPont Merck Pharmaceutical Company, Wilmington, DE, USA', 'institution_ids': ['https://openalex.org/I210824098', 'https://openalex.org/I1316910977']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 17, 'citation_normalized_percentile': {'value': 0.508856, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 83, 'max': 84}, 'biblio': {'volume': '246', 'issue': '2', 'first_page': '171', 'last_page': '178'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10077', 'display_name': 'Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10077', 'display_name': 'Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11337', 'display_name': 'Neuroimmune Interaction in Psychiatric Disorders', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2803', 'display_name': 'Biological Psychiatry'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10056', 'display_name': 'Neurobiological Mechanisms of Drug Addiction and Depression', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/quinpirole', 'display_name': 'Quinpirole', 'score': 0.74092746}, {'id': 'https://openalex.org/keywords/dopamine', 'display_name': 'Dopamine', 'score': 0.493763}], 'concepts': [{'id': 'https://openalex.org/C2776024655', 'wikidata': 'https://www.wikidata.org/wiki/Q410867', 'display_name': 'Monoamine oxidase', 'level': 3, 'score': 0.82482505}, {'id': 'https://openalex.org/C2778296116', 'wikidata': 'https://www.wikidata.org/wiki/Q253187', 'display_name': 'Quinpirole', 'level': 4, 'score': 0.74092746}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.6210044}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.54689485}, {'id': 'https://openalex.org/C187714386', 'wikidata': 'https://www.wikidata.org/wiki/Q420225', 'display_name': 'Monoamine neurotransmitter', 'level': 4, 'score': 0.49829936}, {'id': 'https://openalex.org/C41625074', 'wikidata': 'https://www.wikidata.org/wiki/Q176088', 'display_name': 'Membrane', 'level': 2, 'score': 0.4757804}, {'id': 'https://openalex.org/C2780062018', 'wikidata': 'https://www.wikidata.org/wiki/Q1319792', 'display_name': 'Striatum', 'level': 3, 'score': 0.4204202}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.33554178}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.33157378}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.3241493}, {'id': 'https://openalex.org/C513476851', 'wikidata': 'https://www.wikidata.org/wiki/Q170304', 'display_name': 'Dopamine', 'level': 2, 'score': 0.32117635}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.28711563}, {'id': 'https://openalex.org/C2775864247', 'wikidata': 'https://www.wikidata.org/wiki/Q167934', 'display_name': 'Serotonin', 'level': 3, 'score': 0.27002186}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.26401412}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.1976617}, {'id': 'https://openalex.org/C44208683', 'wikidata': 'https://www.wikidata.org/wiki/Q15335165', 'display_name': 'Dopamine receptor D2', 'level': 3, 'score': 0.15609887}], 'mesh': [{'descriptor_ui': 'D003342', 'descriptor_name': 'Corpus Striatum', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D015259', 'descriptor_name': 'Dopamine Agents', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D004873', 'descriptor_name': 'Ergolines', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D008996', 'descriptor_name': 'Monoamine Oxidase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001058', 'descriptor_name': 'Apomorphine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001058', 'descriptor_name': 'Apomorphine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D001058', 'descriptor_name': 'Apomorphine', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D001667', 'descriptor_name': 'Binding, Competitive', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001667', 'descriptor_name': 'Binding, Competitive', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D003342', 'descriptor_name': 'Corpus Striatum', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003342', 'descriptor_name': 'Corpus Striatum', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D003342', 'descriptor_name': 'Corpus Striatum', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': False}, {'descriptor_ui': 'D015259', 'descriptor_name': 'Dopamine Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004873', 'descriptor_name': 'Ergolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066298', 'descriptor_name': 'In Vitro Techniques', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007700', 'descriptor_name': 'Kinetics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008566', 'descriptor_name': 'Membranes', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D008566', 'descriptor_name': 'Membranes', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': False}, {'descriptor_ui': 'D008566', 'descriptor_name': 'Membranes', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D008566', 'descriptor_name': 'Membranes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008995', 'descriptor_name': 'Monoamine Oxidase', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D008995', 'descriptor_name': 'Monoamine Oxidase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008996', 'descriptor_name': 'Monoamine Oxidase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010620', 'descriptor_name': 'Phenazocine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D010620', 'descriptor_name': 'Phenazocine', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D010620', 'descriptor_name': 'Phenazocine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019257', 'descriptor_name': 'Quinpirole', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017207', 'descriptor_name': 'Rats, Sprague-Dawley', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017448', 'descriptor_name': 'Receptors, Dopamine D2', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D017448', 'descriptor_name': 'Receptors, Dopamine D2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017480', 'descriptor_name': 'Receptors, sigma', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D017480', 'descriptor_name': 'Receptors, sigma', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D017480', 'descriptor_name': 'Receptors, sigma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013134', 'descriptor_name': 'Spiperone', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D013134', 'descriptor_name': 'Spiperone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/0922-4106(93)90095-q', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210192051', 'display_name': 'European Journal of Pharmacology Molecular Pharmacology', 'issn_l': '0922-4106', 'issn': ['0922-4106', '1872-8251'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8104153', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W1623883571', 'https://openalex.org/W1684853394', 'https://openalex.org/W1886668162', 'https://openalex.org/W1954038986', 'https://openalex.org/W1954481876', 'https://openalex.org/W1958486662', 'https://openalex.org/W2010299478', 'https://openalex.org/W2021180718', 'https://openalex.org/W2043813981', 'https://openalex.org/W2061805224', 'https://openalex.org/W2068064905', 'https://openalex.org/W2072796782', 'https://openalex.org/W2074631079', 'https://openalex.org/W2081453158', 'https://openalex.org/W2086143711', 'https://openalex.org/W2128635872', 'https://openalex.org/W2143857681', 'https://openalex.org/W2253312080', 'https://openalex.org/W2263917623', 'https://openalex.org/W2912651169', 'https://openalex.org/W4293247451'], 'related_works': ['https://openalex.org/W4246748827', 'https://openalex.org/W2322941916', 'https://openalex.org/W2071330786', 'https://openalex.org/W2050269602', 'https://openalex.org/W2043067251', 'https://openalex.org/W2005665072', 'https://openalex.org/W1977500429', 'https://openalex.org/W1968559561', 'https://openalex.org/W1963610573', 'https://openalex.org/W1589264845'], 'abstract_inverted_index': {'This': [0, 67], 'study': [1], 'describes': [2], 'interactions': [3], 'of': [4, 39, 50, 70, 78, 100, 143, 149], 'monoamine': [5, 82, 85, 111, 114, 150], 'oxidase': [6, 31, 93, 151], 'inhibitors': [7, 32, 94], 'at': [8, 81], 'binding': [9, 25, 38, 43, 132], 'sites': [10], 'labeled': [11], 'by': [12], '[3H]quinpirole,': [13], 'a': [14, 129], 'putatively': [15], 'selective': [16], 'ligand': [17], 'for': [18, 104, 123, 134, 145], 'dopamine': [19, 90], 'D2-like': [20], 'receptors,': [21], 'in': [22, 23, 27, 41, 136], 'vitro': [24], 'assays': [26, 44], 'rat': [28, 137], 'brain.': [29], 'Monoamine': [30, 92], 'potently': [33], 'and': [34, 117], 'competitively': [35], 'inhibited': [36], 'equilibrium': [37], '[3H]quinpirole': [40, 135], 'homogenate': [42], 'with': [45, 75], 'the': [46, 76, 98, 146], 'following': [47], 'rank': [48, 68], 'order': [49, 69], 'potencies:': [51], 'clorgyline': [52], '⩾': [53], 'Ro': [54, 63], '41-1049': [55], '>': [56, 58, 60, 62, 65], 'pargyline': [57], '(−)-deprenyl': [59], '(+)-deprenyl': [61], '16-6491': [64], 'iproniazid.': [66], 'potencies': [71, 77], 'does': [72], 'not': [73, 96, 109], 'correlate': [74], 'these': [79], 'drugs': [80], 'oxidase-A': [83, 112], 'or': [84, 89, 113], 'oxidase-B,': [86], 'σ': [87, 124], 'site(s)': [88], 'receptors.': [91], 'did': [95, 108], 'alter': [97], 'ability': [99], 'quinpirole': [101], 'to': [102], 'compete': [103], '[3H]spiperone': [105], 'binding.': [106], 'Quinpirole': [107], 'inhibit': [110], 'oxidase-B': [115], 'activity': [116], 'had': [118], 'low': [119], 'affinity': [120], '(200': [121], 'nM)': [122], 'site(s).': [125], 'These': [126], 'data': [127], 'suggest': [128], 'potential': [130], 'novel': [131], 'site': [133, 142], 'brain': [138], 'and/or': [139], 'an': [140], 'alternative': [141], 'action': [144], 'antidepressant': [147], 'effects': [148], 'inhibitors.': [152]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2068364191', 'counts_by_year': [], 'updated_date': '2024-08-15T08:04:59.829006', 'created_date': '2016-06-24'}